{
  "version": "2.0.0",
  "id": "ngn_sa_highlight_vf_safety_stop_001",
  "questionSource": "internal",
  "questionType": "standalone_highlight",
  "item": {
    "stem": "The nurse in the intensive care unit (ICU) is preparing to administer scheduled medications for a client who is 1 hour post-cardiac arrest with return of spontaneous circulation (ROSC). The nurse reviews the client's electronic health record.",
    "prompt": "Click to highlight the findings in the record that together indicate the nurse should **withhold a medication** and **notify the provider immediately**."
  },
  "questionPayload": {
    "tabs": [
      {
        "id": "tab1",
        "title": "Nurses' Notes",
        "content": "0800: Client is a 68-year-old male with a history of hypertension and coronary artery disease, admitted to the ICU after an out-of-hospital cardiac arrest. The client was found unresponsive at a community center; bystander CPR was initiated, but the first shock was delayed due to lack of an on-site AED. Per EMS report, the initial rhythm was Ventricular Fibrillation. Client achieved ROSC in the emergency department after 3 defibrillations, epinephrine, and amiodarone 300 mg IV push. He is now intubated and sedated on a propofol infusion. Hemodynamically supported with a norepinephrine infusion. Suspected cause is an acute ST-elevation myocardial infarction (STEMI)."
      },
      {
        "id": "tab2",
        "title": "Vitals & Diagnostics",
        "content": "**Vital Signs @ 0800:**\n- Heart Rate: 92/min\n- Blood Pressure: 94/52 mmHg (MAP 66 mmHg)\n- Respiratory Rate: 16/min (ventilator-controlled)\n- SpO2: 95% on FiO2 60%\n- Temperature: 36.1°C (97.0°F)\n\n**Laboratory Results @ 0730:**\n- Potassium: 3.2 mEq/L (3.5-5.0 mEq/L)\n- Magnesium: 1.7 mg/dL (1.7-2.2 mg/dL)\n- Troponin I: 15.2 ng/mL (<0.04 ng/mL)\n- Lactate: 4.8 mmol/L (0.5-2.2 mmol/L)\n- BUN: 25 mg/dL (10-20 mg/dL)\n\n**ECG Interpretation (Post-ROSC):**\n- Sinus rhythm with a corrected QT interval (QTc) of 520 ms."
      },
      {
        "id": "tab3",
        "title": "Medication Administration Record",
        "content": "**Infusions:**\n- Norepinephrine infusion at 10 mcg/min\n- Propofol infusion at 30 mcg/kg/min\n\n**Scheduled Medications (Due @ 0830):**\n- Amiodarone 150 mg IVPB over 10 minutes\n- Potassium Chloride 20 mEq IVPB over 1 hour\n- Furosemide 20 mg IV push"
      }
    ],
    "highlightablePhrases": [
      "intubated and sedated on a propofol infusion",
      "first shock was delayed due to lack of an on-site AED",
      "Blood Pressure: 94/52 mmHg (MAP 66 mmHg)",
      "Potassium: 3.2 mEq/L",
      "Troponin I: 15.2 ng/mL",
      "Sinus rhythm with a corrected QT interval (QTc) of 520 ms",
      "Norepinephrine infusion at 10 mcg/min",
      "Amiodarone 150 mg IVPB over 10 minutes",
      "Potassium Chloride 20 mEq IVPB over 1 hour"
    ],
    "correctHighlightAnswers": [
      "Potassium: 3.2 mEq/L",
      "Sinus rhythm with a corrected QT interval (QTc) of 520 ms",
      "Amiodarone 150 mg IVPB over 10 minutes"
    ]
  },
  "rationale": {
    "correct": "The combination of hypokalemia (Potassium 3.2 mEq/L) and a prolonged QTc interval (520 ms) creates a significant risk of Torsades de Pointes (TdP), a life-threatening ventricular arrhythmia. Amiodarone, a Class III antiarrhythmic, prolongs the QT interval. Administering amiodarone (Amiodarone 150 mg IVPB over 10 minutes) in this scenario further increases the risk of TdP. Hypokalemia reduces the threshold for QT prolongation and increases myocardial excitability, exacerbating the effects of amiodarone. The nurse must withhold the amiodarone and immediately notify the provider to discuss alternative antiarrhythmic strategies and address the hypokalemia.",
    "incorrect": "Highlighting individual findings without considering their combined effect is incorrect. While hypotension and elevated troponin are expected post-arrest, they don't directly contraindicate amiodarone in isolation. Potassium chloride is indicated to correct hypokalemia. The delayed defibrillation explains the patient's condition but doesn't directly relate to the amiodarone contraindication. Propofol is used for sedation post-arrest. Norepinephrine supports blood pressure.",
    "answerBreakdown": [
      {
        "label": "Correct Highlight",
        "content": "Sinus rhythm with a corrected QT interval (QTc) of 520 ms",
        "isCorrect": true,
        "justification": "A QTc > 500 ms is severely prolonged, indicating increased risk of Torsades de Pointes (TdP). This is a primary contraindication for QT-prolonging drugs like amiodarone. The prolonged QT reflects delayed ventricular repolarization, making the heart vulnerable to life-threatening arrhythmias. This is due to ion channel dysfunction and altered repolarization currents, often exacerbated by ischemia and electrolyte imbalances following cardiac arrest."
      },
      {
        "label": "Correct Highlight",
        "content": "Potassium: 3.2 mEq/L",
        "isCorrect": true,
        "justification": "Hypokalemia enhances the QT-prolonging effects of drugs like amiodarone and increases the risk of TdP. Low potassium levels disrupt the normal repolarization of cardiac cells, making them more susceptible to arrhythmias. Hypokalemia reduces the outward potassium current (IKr), further prolonging the action potential duration and increasing the risk of early afterdepolarizations (EADs), which can trigger TdP."
      },
      {
        "label": "Correct Highlight",
        "content": "Amiodarone 150 mg IVPB over 10 minutes",
        "isCorrect": true,
        "justification": "Amiodarone is a Class III antiarrhythmic that prolongs the QT interval. Administering it to a patient with a pre-existing prolonged QTc and hypokalemia significantly increases the risk of TdP. Amiodarone blocks potassium channels, further delaying ventricular repolarization and prolonging the QT interval. This effect, combined with hypokalemia, creates a 'perfect storm' for TdP."
      },
      {
        "label": "Incorrect Highlight",
        "content": "intubated and sedated on a propofol infusion",
        "isCorrect": false,
        "justification": "Intubation and sedation with propofol are standard post-cardiac arrest interventions to manage ventilation and reduce metabolic demand. Propofol helps decrease cerebral oxygen consumption and provides amnesia, aiding in neurological recovery. It does not directly contraindicate the scheduled medications."
      },
      {
        "label": "Incorrect Highlight",
        "content": "first shock was delayed due to lack of an on-site AED",
        "isCorrect": false,
        "justification": "This historical information explains the patient's current condition but does not create a specific contraindication for administering amiodarone. The delay likely contributed to the severity of the myocardial injury and the subsequent metabolic derangements, but it's not a direct reason to withhold amiodarone in the presence of prolonged QTc and hypokalemia."
      },
      {
        "label": "Incorrect Highlight",
        "content": "Blood Pressure: 94/52 mmHg (MAP 66 mmHg)",
        "isCorrect": false,
        "justification": "While amiodarone can cause hypotension, the patient is already receiving norepinephrine to manage blood pressure. The hypotension is likely due to cardiogenic shock post-arrest. The norepinephrine infusion is addressing this, making the blood pressure itself not an absolute contraindication without provider consultation."
      },
      {
        "label": "Incorrect Highlight",
        "content": "Troponin I: 15.2 ng/mL",
        "isCorrect": false,
        "justification": "Elevated troponin confirms myocardial infarction, the likely cause of the cardiac arrest. This supports the need for antiarrhythmic therapy but is not a contraindication to amiodarone in isolation. The elevated troponin indicates myocardial cell damage and release of intracellular proteins into the bloodstream."
      },
      {
        "label": "Incorrect Highlight",
        "content": "Norepinephrine infusion at 10 mcg/min",
        "isCorrect": false,
        "justification": "Norepinephrine is a vasopressor used to maintain blood pressure and organ perfusion post-arrest. It is a necessary intervention to support hemodynamics and does not indicate a problem. Norepinephrine stimulates alpha-adrenergic receptors, causing vasoconstriction and increasing blood pressure."
      },
      {
        "label": "Incorrect Highlight",
        "content": "Potassium Chloride 20 mEq IVPB over 1 hour",
        "isCorrect": false,
        "justification": "Potassium chloride is the appropriate treatment for hypokalemia. Administering potassium is essential to stabilize the myocardium and reduce arrhythmia risk. It should be administered, not withheld. Potassium supplementation helps restore normal intracellular potassium concentrations, improving cardiac cell repolarization and reducing the risk of arrhythmias."
      }
    ]
  },
  "pedagogy": {
    "bloomLevel": "Analyzing",
    "cjmmStep": "Analyze Cues",
    "nclexCategory": "Reduction of Risk Potential",
    "difficulty": "Level 5 - Highly Discriminating",
    "topicTags": [
      "Ventricular Fibrillation",
      "Post-Cardiac Arrest Care",
      "Pharmacology",
      "Amiodarone",
      "QT Prolongation",
      "Torsades de Pointes",
      "Medication Safety",
      "Critical Care",
      "Electrolyte Imbalance"
    ]
  },
  "effectiveDate": "2026-04-01",
  "clinicalPearls": [
    "A prolonged QTc interval (>500ms) in combination with hypokalemia significantly increases the risk of Torsades de Pointes, especially when administering QT-prolonging medications like amiodarone.",
    "Always assess a patient's electrolyte levels and ECG findings before administering medications known to affect the QT interval.",
    "Post-cardiac arrest patients require careful monitoring and assessment to prevent life-threatening complications. Prioritize identifying and addressing modifiable risk factors."
  ],
  "sbar": {
    "situation": "The client is a 68-year-old male, 1 hour post-cardiac arrest with ROSC, admitted to the ICU for management of suspected STEMI.",
    "background": "The client experienced out-of-hospital cardiac arrest due to Ventricular Fibrillation. ROSC was achieved after defibrillation, epinephrine, and amiodarone. The client is intubated, sedated with propofol, and receiving norepinephrine for blood pressure support.",
    "assessment": "Current assessment at 0800: HR 92 bpm, BP 94/52 mmHg (MAP 66 mmHg), RR 16 (ventilator-controlled), SpO2 95% on FiO2 60%, Temp 36.1°C. Labs at 0730: Potassium 3.2 mEq/L, Magnesium 1.7 mg/dL, Troponin I 15.2 ng/mL, Lactate 4.8 mmol/L, BUN 25 mg/dL. ECG: Sinus rhythm with QTc 520 ms. Scheduled medications due at 0830 include amiodarone 150 mg IVPB.",
    "recommendation": "I recommend withholding the scheduled amiodarone 150 mg IVPB due at 0830 due to the prolonged QTc interval of 520 ms and hypokalemia of 3.2 mEq/L, which significantly increases the risk of Torsades de Pointes. I request immediate provider notification to discuss alternative antiarrhythmic options and potassium repletion strategies."
  },
  "sentinelStatus": "healed_v2026_v8"
}